| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Nov 2024 | 8 Nov 2024 |
| GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve and take on record the un-audited financial results for the quarter and half year ended September 30 2024 amongst other routine matters. Submission of unaudited financial results of the Company and Limited review report for Quarter and Half Year Ended September 30, 2024 (As per BSE Announcement Dated on 14/11/2024) | ||
| Board Meeting | 14 Aug 2024 | 9 Aug 2024 |
| GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve the un-audited Financial Results/Statements for the quarter ended June 30 2024 and other business items Un-Audited Financial Results for the Quarter Ended on 30.06.2024 (As Per BSE Announcement dated on 14.08.2024) | ||
| Board Meeting | 30 May 2024 | 24 May 2024 |
| GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve audited financial results/statements for the quarter and year ended on 31st March 2024 Outcome of the Board Meeting of Godavari Drugs Limited (the Company) held on Thursday 30th May, 2024 Financial results for the Quarter and year ended on 31st March 2024 (As Per BSE Announcement Dated on 30.05.2024) | ||
| Board Meeting | 13 Feb 2024 | 6 Feb 2024 |
| GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday February 14th 2023 inter alia to approve and take on record the un-audited financial results for the quarter ended December 31 2023 amongst other routine matters. The trading window for dealing in securities of the Company for all insiders as defined under the Code of Conduct for Prevention of Insider Trading (the Code) of the Company has been closed from Saturday December 30 2023 to Friday February 16 2024 (both days inclusive) in compliance with the provisions of the Code of the Company read with SEBI (Prohibition of Insider Trading) Regulations 2015. Accordingly the trading window will be opened from Saturday February 17 2024. This is for your information and records. The Board Meeting to be held on 14/02/2024 has been revised to 13/02/2024 The Board Meeting to be held on 14/02/2024 has been revised to 13/02/2024 (As Per BSE Announcement dated on 07.02.2024) Outcome of the Board Meeting of Godavari Drugs Limited (the Company) held on Tuesday 13th February, 2024 Un-Audited Financial Results and Limited Review Report for the Quarter ended 31st December, 2023 (As Per BSE Announcement Dated on 13/02/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
